ASCENDIS HEALTH LIMITED - Dealings in securities by directors

Dealings in securities by directors

ASCENDIS HEALTH LIMITED
(Incorporated in the Republic of South Africa)
(Registration number 2008/005856/06)
ISIN: ZAE000185005 Share code: ASC
(“Ascendis”)

Dealings in securities by directors

In terms of paragraphs 3.63 to 3.74 of the JSE Listings Requirements, the following information,
relating to dealings in securities by directors, is disclosed:

Directors:                            Gary Shayne and Crispian Dillon.

Nature of the transaction:            Coast2Coast Capital Proprietary Limited (“C2C”) (in
                                      which Gary Shayne holds an 85% indirect interest and
                                      Crispian Dillon holds a 15% indirect interest), is
                                      required to redeem two existing debentures issued in
                                      2014 by an indirect subsidiary of C2C by way of a
                                      settlement of Ascendis shares. The Ascendis shares
                                      are thus transferred to effect the redemption of the
                                      debentures at pre-determined discounts to the 30 day
                                      volume weighted average prices on 2 December 2016
                                      and 5 December 2016, being R25.15 and R25.00
                                      respectively. The discounts were applied to achieve
                                      an agreed return on the debentures and therefore
                                      should not be used to evaluate a fair share price for
                                      Ascendis in the open market.
Debenture 1:

Number of shares:                     456,103

Price per share:                      R21.925

Value:                                R10,000,058

Date of transaction:                  15 December 2016

Class of shares:                      Ordinary shares

Nature of transaction:                Sale, off market

Extent of interest:                   Indirect beneficial (through C2C, in which Gary
                                      Shayne has a 85% indirect beneficial interest and
                                      Crispian Dillon has a 15% indirect beneficial interest).

Written clearance obtained:           Clearance was obtained from the Chairman.

Debenture 2:

Number of shares:                     883,588

Price per share:                      R22.635

Value:                                R20,000,014

Date of transaction:                  15 December 2016

Class of shares:                      Ordinary shares

Nature of transaction:                Sale, off market

Extent of interest:                   Indirect beneficial (through C2C, in which Gary
                                      Shayne has a 85% indirect beneficial interest and
                                      Crispian Dillon has a 15% indirect beneficial interest).

Written clearance obtained:           Clearance was obtained from the Chairman.



19 December 2016

Johannesburg

Sponsor

Investec Bank Limited

Date: 19/12/2016 05:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.